Afatinib CAS 439081-18-2 Bohloeki >99.5% (HPLC) Factory

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: Afatinib

Mantsoe a tšoanang: BIBW2992

CAS: 439081-18-2

Bohloeki: >99.5% (HPLC)

Ponahalo: Phofo e Ntle-Bosoeu

E-Mail: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale Afatinib
Litlhaloso tse tšoanang BIBW2992;BIBW-2992;BIBW2992 Free Base;Tomtovok;(S,E)-N-(4-(3-Chloro-4-Fluorophenylamino)-7-(Tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(Dimethylamino)but-2-Enamide
Nomoro ea CAS 439081-18-2
Nomoro ea KAtse RF-PI2033
Boemo ba Setoko Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule C24H25ClFN5O3
Boima ba Molek'hule 485.94
Solubility E qhibiliha ka DMSO
Botenya 1.380
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e Ntle-Tšweu
Boitsebiso HPLC, NMR
Mokhoa oa Bohloeki / Analysis >99.5% (HPLC)
Melting Point 100.0 ~ 102.0℃
Tahlehelo ka ho Omisa <0.50%
Masalla a ho Ignition <0.20%
Litšila ka Kakaretso <0.50%
Litšepe tse boima ≤20ppm
Sekhahla sa NMR E Ikamahanya le Sebopeho
Tekanyetso ea Teko Maemo a Khoebo
Shelf Life Likhoeli tse 24 Haeba li Behiloe Hantle
Tšebeliso API;Afatinib;Afatinib Dimaleate;NSCLC

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo

Melemo:

1

LBH:

Kopo:

Afatinib, eo hape e tsejoang e le BIW-2992, (CAS: 439081-18-2) ke moloko oa bobeli o matla le o ke keng oa fetoloa oa inhibitor ea epidermal growth factor receptor (EGFR) le human epidermal growth factor receptor 2 (HER2) tyrosine kinase, e ntlafalitsoeng ke Boehringer Ingelheim, Jeremane.E khona ho thibela mosebetsi oa tyrosine kinase ka mokhoa o ke keng oa fetoloa ka ho itšoara ka Michael le sehlopha sa thiol sa cysteine ​​​​e boemong ba 797 ba EGFR.Ka la 12 Phupu, 2013, e ile ea fetoha setlhare se secha bakeng sa mofetše o monyane oa lisele tsa matšoafo o amohetsoeng ke US FDA tlasa lebitso la khoebo la Gilotrif.Setlhare sena ke letlapa.E sebelisoa bakeng sa kalafo ea bakuli ba fumanoeng ba e-na le mofetše oa metastatic o seng o nyane oa sele ea matšoafo (NSCLC) ka tahlehelo ea phetoho ea 19th exon kapa L858R ho 21th exon ea tumor epidermal growth factor receptor (EGFR) e netefalitsoeng ho sebelisoa kit e amohetsoeng. ka FDA.Setlhare sena se boetse se sebetsa hantle kalafong ea bakuli ba nang le HER2 ba nang le mofetše oa matsoele o tsoetseng pele.Afatinib ke ea sehlopha sa lithethefatsi tse tsejoang e le tyrosine kinase inhibitors.Tyrosine kinase inhibitors e etselitsoe ho thibela ketso ea enzyme e itseng e bitsoang tyrosine kinase.Enzyme ena e bapala karolo e kholo ts'ebetsong ea lisele, 'me e sebetsa ka mafolofolo ho holiseng le ho tsoela pele ha hlahala.Afatinib e sebetsa ho thibela tšebetso ea mefuta e 'meli ea tyrosine kinases: epidermal growth factor receptor (EGFR) le Her2, tse "hlahisoang ho feta" ke mefuta e mengata ea kankere.Ka ho thibela tšebetso ea tyrosine kinase tsena, Afatinib e ka thibela lisele tsa mofetše ho arohana le ho hola.

Ngola molaetsa wa hao mona mme o re romele wona